Nuclear co-expression of p14 ARF and p16 INK4A in uterine cervical cancer-derived cell lines containing HPV

Cancer Biomarkers

Volumn 8, Issue 6, 2010, Pages 341-350

  Vázquez Vega, Salvador ^a   Sánchez Suárez, Lilia Patricia ^b   Contreras Paredes, Adriana ^d   Castellanos Juárez, Emilio ^b   Peñarroja Flores, Rubicelia ^b   Lizano Soberón, Marcela ^c,d   Andrade Cruz, Rafael ^a   García Carrancá, Alejandro ^c,d   Benítez Bribiesca, Luis ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ONCOLOGÍA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d SECRETARÍA DE SALUD   (Mexico)

Author keywords

Cervical cancer cell lines; cervical cancer markers; p14 ARF; p16 INK4A

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; TUMOR MARKER;

ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS; WESTERN BLOTTING;

CATHEPSINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 80955139694     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2011-0223     Document Type: Article

References (27)

1. IARC World Cancer Report 2008. Boyle P, Levin B, editors: [http://www.iarc.fr/en/publications/pdfsonline/ wcr/2008/wcr 2008.pdf].
2. ACOGPracticeBulletin: ClinicalManagementGuidelines for Obstetrician-Gynecologists, Number 109 (December 2009).
3. V. Madrid-Marina, K. Torres-Poveda, G. López-Toledo and A. García-Carranca. Advantages and disadvantages of current prophylactic vaccines against HPV. Arch Med Res (2009), 40:471-477.
4. K.J. Syrjänen, Immunohistochemistry in assessment ofmolecular pathogenesis of cervical carcinogenesis, Eur J Gynaecol Oncol 26 (2005), 5-19. (Pubitemid 40314060)
5. D.P. Malinowski, Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection, Expert Rev Mol Diagn 7 (2007), 117-131.
6. N. Wentzensen and M.D. von Knebel, Biomarkers in cervical cancer screening, Dis Markers 23 (2007), 315-330. (Pubitemid 47015791)
7. G.Vazquez-Ortiz, P. Pina-Sanchez, K.Vazquez, A.Duenas, L. Taja, P.Mendoza, J.A.Garcia andM. Salcedo, Overexpression of cathepsin F,matrix metalloproteinases 11 and 12 in cervical cancer, BMC Cancer 30 (2005), 68.
8. C.B. Woodman, S.I. Collins and L.S. Young. The natural history of cervical HPV infection: unresolved issues, Nat Rev Cancer 7 (2007), 11-22. (Pubitemid 46020844)
9. H. zur Hausen, Papillomaviruses in the causation of human cancers - a brief historical account, Virology 20 (2009), 260-265.
10. Y Guo, S. Pajovic and B.L. Gallie, Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma, Biochem Biophys Res Commun 10 (2008), 1-5.
11. N.E. Sharpless, INK4a/ARF: Amultifunctional tumor suppressor locus, Mutat Res 25 (2005), 22-38. (Pubitemid 40982680)
12. R. Klaes, T. Friedrich, D. Spitkovsky, R. Ridder, W. Rudy, U. Petry, G. Dallenbach-Hellweg, D. Schmidt and M.D. von Knebel, Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri, Int J Cancer 15 (2001), 276-284. (Pubitemid 32225381)
13. M.J. Trunk, G. Dallenbach-Hellweg, R. Ridder, K.U. Petry, H. Ikenberg, V. Schneider andM.D. von Knebel, Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples, Acta Cytol 48 (2004), 771-782. (Pubitemid 39518255)
14. I. Tsoumpou, M. Arbyn, M. Kyrgiou, N. Wentzensen, G. Koliopoulos, P. Martin-Hirsch, V. Malamou-Mitsi and E. Paraskevaidis, p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis, Cancer Treat Rev 35 (2009), 210-220.
15. K.D. Robertson and P.A. Jones, The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53,Mol Cell Biol 18 (1998), 6457-6473. (Pubitemid 28500536)
16. S.L. Harris and A.J. Levine, The p53 pathway: positive and negative feedback loops, Oncogene 18 (2005), 2899-2908. (Pubitemid 40638098)
17. J. Bulten, I.A. van der Avoort, W.J. Melchers, L.F. Massuger, J.M. Grefte, A.G. Hanselaar and P.C. de Wilde, p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia, Gynecol Oncol 101 (2006), 487-494. (Pubitemid 43729973)
18. W. Feng, J. Xiao, Z. Zhang, D.G. Rosen, R.E. Brown, J. Liu and X. Duan, Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma, Mod Pathol 9 (2007), 961-966. (Pubitemid 47267824)
19. M. Scheffner, K. Münger, J.C. Byrne and P.M. Howley, The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines, Proc Natl Acad Sci USA 1 (1991), 5523-5527. (Pubitemid 21914777)
20. F. Kurshumliu, C. Thorns and L. Gashi-Luci, p16INK4A in routine practice as a marker of cervical epithelial neoplasia, Gynecol Oncol 115 (2009), 127-131.
21. M. Branca, M. Ciotti, C. Giorgi, D. Santini, L. Di Bonito, S. Costa, A. Benedetto, D. Bonifacio, P. Di Bonito, P. Paba, L. Accardi, S. Syrjänen, C. Favalli and K. Syrjänen, HPVPathogen ISS Study Group. Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer, Eur J Obstet Gynecol Reprod Biol 130 (2007), 223-231. (Pubitemid 46097249)
22. M.T. Galgano, P.E. Castle, K.A. Atkins, W.K. Brix, S.R. Nassau and M.H. Stoler, Using biomarkers as objective standards in the diagnosis of cervical biopsies, Am J Surg Pathol 34 (2010), 1077-1087.
23. A. Schröpfer, U. Kammerer, M. Kapp, J. Dietl, S. Feix and J. Anacker, Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines, BMC Cancer 10 (2010), 553.
24. D. Utrera-Barillas, M. Salcedo-Vargas, P. Gariglio-Vidal, D.M. Hernändez-Hernández, F. Gutiérrez-Delgado and L. Benítez-Bribiesca, H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix, Arch Med Res 31 (2000), 172-181. (Pubitemid 30392354)
25. N. Murphy, M. Ring, A.G. Killalea, V. Uhlmann, M. ÓDonovan, F. Mulcahy et al: p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and Thin PrepTM smears, J Clin Pathol 56 (2003), 56-63. (Pubitemid 36132476)
26. K. Evangelou, J. Bramis, I. Peros, P. Zacharatos, D. Dasiou- Plakida, N. Kalogeropoulos, P.J. Asimacopoulos, C. Kittas, E. Marinos and V.G. Gorgoulis, Electron microscopy evidence that cytoplasmic localization of the p16(INK4A) "nuclear" cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas, Biotech Histochem 79 (2004), 5-10. (Pubitemid 38997099)
27. F.J.Stott, S. Bates, M.C. James, B.B. McConnell, M. Starborg, S. Brookes, I.K. Ryan, E. Hara, K.H. Vousden and G. Peters, The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2, EMBO J 17 (1998), 5001-5014. (Pubitemid 28408466)